OBJECTIVE

To examine the association between age at menarche and risk of gestational diabetes mellitus (GDM).

RESEARCH DESIGN AND METHODS

A prospective cohort study of 42,109 eligible pregnancies from 27,482 women in the Nurses’ Health Study II.

RESULTS

The adjusted risk ratios for GDM across the age at menarche categories (≤11, 12, 13, and ≥14 years) were 1.34 (95% CI 1.14–1.58), 1.13 (0.97–1.31), 1.11 (0.95–1.29), and 1.00 (referent; P for trend = 0.0005), respectively. Analysis of the mediating effect indicated that 42.1% (P = 0.0007) of the association was mediated through prepregnancy BMI.

CONCLUSIONS

These findings suggested that earlier menarche was significantly associated with an increased risk of GDM. This association was largely mediated through prepregnancy excessive body adiposity.

Gestational diabetes mellitus (GDM) is one of the most common pregnancy complications, affecting ∼2–7% of all pregnancies in the U.S. (1). Identifying women who are at high risk of GDM has important public health and clinical significances. Menarche is an indicator of pubertal onset and the beginning of reproductive life in women. Although early menarche has been associated with risk factors for GDM, such as insulin resistance (2,3) and obesity (46), the association between age at menarche and risk of GDM has yet to be investigated. The objective of this study was to examine the association between menarche timing and GDM risk, and the extent to which the association is mediated through prepregnancy obesity.

The Nurses’ Health Study II, initiated in 1989, is an ongoing prospective cohort of U.S. female nurses. For the current study, the final sample included 27,482 women (42,109 eligible pregnancies) who did not have diabetes and other major chronic diseases at baseline or prior to GDM, and were observed until 2001 (after which most women had passed the reproductive age).

GDM events were identified based on self-reported information and updated every 2 years. A previous validation study (7) demonstrated a high validity of self-reported diagnosis of GDM in this cohort (94% of women who reported to have GDM were confirmed by a physician review based on medical record review). Age at menarche was defined as the age of the first menstruation and was collected in 1989 (baseline questionnaire).

Age at menarche was grouped into a categorical variable (≤11, 12, 13, and ≥14 years of age) to ensure adequate sample size in each age category. Log-binomial models were performed to estimate the risk ratio (RR) and 95% CI of GDM associated with age at menarche, with generalized estimating equations assuming a similar within-person correlation across two or more pregnancies for a single woman. Multivariate regression models were applied to control for potential confounding factors. The mediating effect was evaluated by calculating the mediation proportion that represents the proportion for excess risk of GDM that can be attributed to a mediator.

We documented 1,404 pregnancies complicated by GDM (346 were recurrent GDM) among 27,482 women (92% were Caucasian). The mean age at menarche was 12.6 ± 1.5 years, and the median was 12.0 years. In general, women with an earlier age at menarche had a lower birth weight, a larger body size at age 5 and 10 years, a greater BMI at age 18 years, and a greater weight gain since age 18 years (Supplementary Table 1). Moreover, they were more likely to be overweight or obese before pregnancy, to have a higher BMI at 18 years of age and before the index pregnancy, and to gain more weight since 18 years of age than women with older ages at menarche. Early menarche was significantly associated with an increased risk of GDM (Table 1). After adjusting for age, race/ethnicity, and family history of diabetes, pregnancies among women with menarche at ≤11 years of age had a 39% increased risk of GDM (RR 1.39, 95% CI 1.19–1.63) compared with pregnancies among women with menarche at 14 years of age (referent) (multivariate model 1). The association did not change, and the trend remained significant with additional adjustment for women’s birth weight, and somatotype at ages 5 and 10 years (P for trend = 0.0003; multivariate model 2), suggesting that the association between age at menarche and GDM is not confounded by intrauterine and childhood adiposity before the onset of menarche. After further adjustment for adulthood lifestyle factors (i.e., alcohol consumption, smoking status, Alternate Healthy Eating Index 2010, total physical activity, marital status, and oral contraceptive use in model 3), the RRs across the menarche categories (≤11, 12, 13, and ≥14 years of age) were 1.34 (95% CI 1.14–1.58), 1.13 (0.97–1.31), 1.11 (0.95–1.29), and 1.00 (referent; P for trend = 0.0005; multivariate model 3), respectively, indicating that the association is independent of adulthood lifestyle factors.

Table 1

Relative risk (95% CI) of GDM according to age at menarche among 42,109 pregnancies in the Nurses’ Health Study II (1,404 GDM events)

Age at menarcheGDM (events/pregnancies)Multivariate model 1Multivariate model 2Multivariate model 3
≤11 years 361/8,730 1.39 (1.19–1.63) 1.36 (1.16–1.60) 1.34 (1.14–1.58) 
12 years 405/12,335 1.13 (0.97–1.32) 1.13 (0.97–1.31) 1.13 (0.97–1.31) 
13 years 381/11,980 1.10 (0.95–1.29) 1.11 (0.95–1.29) 1.11 (0.95–1.29) 
≥14 years 257/9,064 Reference Reference Reference 
P for trend  <0.0001 0.0003 0.0005 
Age at menarcheGDM (events/pregnancies)Multivariate model 1Multivariate model 2Multivariate model 3
≤11 years 361/8,730 1.39 (1.19–1.63) 1.36 (1.16–1.60) 1.34 (1.14–1.58) 
12 years 405/12,335 1.13 (0.97–1.32) 1.13 (0.97–1.31) 1.13 (0.97–1.31) 
13 years 381/11,980 1.10 (0.95–1.29) 1.11 (0.95–1.29) 1.11 (0.95–1.29) 
≥14 years 257/9,064 Reference Reference Reference 
P for trend  <0.0001 0.0003 0.0005 

Data are reported as RR (95% CI), unless otherwise indicated. Model 1, covariates include age (continuous), family history of diabetes (yes, no), and race/ethnicity (Caucasian, African American, Asian American, Hispanic, other); model 2, covariates include those in model 1, birth weight (<5.5, 5.5–6.9, 7.0–8.4, 8.5–10.0, or >10.0 pounds), somatotype at age 5 years (1, 2, 3, 4, 5+), and somatotype at age 10 years (1, 2, 3, 4, 5+); and model 3, covariates include those in model 2, and alcohol consumption (4 categories, grams/day), smoking status (4 categories), Alternate Healthy Eating Index 2010 (quintiles), total physical activity (quintiles of METs/week), marital status (yes vs. no), and oral contraceptive use (yes vs. no).

To further understand how body weight/adiposity after the onset of menarche impacts the menarche-GDM association, we tested the results by adding adolescent and adulthood BMI in the multivariate models. Additional adjustment for BMI at 18 years of age did not materially change the results. The association, however, was substantially attenuated and became statistically insignificant after further adjustment of prepregnancy BMI (data not shown). We further calculated the proportions of effects mediated through prepregnancy BMI. The estimated proportion for excess risk of GDM was 42.1% (95% CI 17.9–66.3, P = 0.0007) for prepregnancy BMI, indicating that prepregnancy BMI was a mediator for the associations between age at menarche and GDM risk.

Two major findings were observed from this prospective study of 42,109 pregnancies among 27,482 women. First, earlier menarche was significantly associated with an increased risk of GDM, independent of established risk factors, such as age, parity, family history of diabetes, smoking, oral contraceptive use, physical activity, birth weight, and childhood adiposity. Second, the association between age at menarche and GDM risk might be partly mediated through prepregnancy obesity.

We were aware of one previous study that examined the relationship between age at menarche and GDM among 3,419 women (185 GDM events), and reported no association. Our findings provide new evidence that earlier menarche is associated with GDM and are generally in agreement with several recent large cohort studies (813) in which earlier menarche was significantly associated with an increased risk of type 2 diabetes in middle- to old-aged adults. The precise mechanism by which early age at menarche may increase the risk of GDM is not clear. Early menarche has been associated with risk factors for GDM such as excessive prepregnancy obesity (46) and insulin resistance (2,3). In the current study, the observed association was substantially attenuated after adjusting for prepregnancy BMI. The estimated proportion of risk of GDM that was mediated by prepregnancy BMI was 42.1%, suggesting that prepregnancy adiposity may play an important role in mediating this association. Other pathways might also be implicated in the association between age at menarche and GDM. Earlier age at menarche was associated with adulthood higher estrogen levels and lower serum sex hormone–binding globulin levels among women (14). High plasma estradiol and testosterone and/or low sex hormone–binding globulin levels were also associated with a higher risk of GDM (15), independent of adiposity. Therefore, it is plausible that age at menarche may be related to GDM risk through its association with hormonal changes. Future studies to investigate the underlying mechanisms are warranted.

In summary, earlier age at menarche was associated with an elevated risk of GDM. A large proportion, but not all, of this association was mediated through excessive adiposity before pregnancy. Early age at menarche might represent another risk factor for the early identification of girls who are at increased risk of the development of GDM in adulthood.

Funding. The Nurses’ Health Study II was funded by research grants CA-50385 and DK-58845 from the National Institutes of Health. When this study was conducted, L.C., S.L., Y.Z., G.M.B.L., E.Y., and C.Z. were supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Author Contributions. L.C. conceived and designed the study, conducted statistical analyses, and wrote the first draft of the manuscript. S.L. conceived and designed the study and conducted statistical analyses. C.H. conceived and designed the study. Y.Z. interpreted results and revised the manuscript. G.M.B.L. and E.Y. contributed to discussions. F.B.H. acquired data. C.Z. conceived and designed the study, and acquired data. All authors interpreted results and revised the manuscript. L.C. and C.Z. are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

1.
American Diabetes Association
.
Gestational diabetes mellitus
.
Diabetes Care
2004
;
27
(
Suppl. 1
):
S88
S90
[PubMed]
2.
Feng
Y
,
Hong
X
,
Wilker
E
, et al
.
Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases
.
Atherosclerosis
2008
;
196
:
590
597
[PubMed]
3.
Kivimäki
M
,
Lawlor
DA
,
Smith
GD
, et al
.
Association of age at menarche with cardiovascular risk factors, vascular structure, and function in adulthood: the Cardiovascular Risk in Young Finns study
.
Am J Clin Nutr
2008
;
87
:
1876
1882
[PubMed]
4.
Laitinen
J
,
Power
C
,
Järvelin
MR
.
Family social class, maternal body mass index, childhood body mass index, and age at menarche as predictors of adult obesity
.
Am J Clin Nutr
2001
;
74
:
287
294
[PubMed]
5.
Freedman
DS
,
Khan
LK
,
Serdula
MK
,
Dietz
WH
,
Srinivasan
SR
,
Berenson
GS
;
Bogalusa Heart Study
.
The relation of menarcheal age to obesity in childhood and adulthood: the Bogalusa Heart Study
.
BMC Pediatr
2003
;
3
:
3
[PubMed]
6.
Pierce
MB
,
Leon
DA
.
Age at menarche and adult BMI in the Aberdeen children of the 1950s cohort study
.
Am J Clin Nutr
2005
;
82
:
733
739
[PubMed]
7.
Solomon
CG
,
Willett
WC
,
Carey
VJ
, et al
.
A prospective study of pregravid determinants of gestational diabetes mellitus
.
JAMA
1997
;
278
:
1078
1083
[PubMed]
8.
Saquib
N
,
Kritz-Silverstein
D
,
Barrett-Connor
E
.
Age at menarche, abnormal glucose tolerance and type 2 diabetes mellitus: the Rancho Bernardo Study
.
Climacteric
2005
;
8
:
76
82
[PubMed]
9.
Lakshman
R
,
Forouhi
N
,
Luben
R
, et al
.
Association between age at menarche and risk of diabetes in adults: results from the EPIC-Norfolk cohort study
.
Diabetologia
2008
;
51
:
781
786
[PubMed]
10.
He
C
,
Zhang
C
,
Hunter
DJ
, et al
.
Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies
.
Am J Epidemiol
2010
;
171
:
334
344
[PubMed]
11.
Stöckl
D
,
Döring
A
,
Peters
A
, et al
.
Age at menarche is associated with prediabetes and diabetes in women (aged 32-81 years) from the general population: the KORA F4 Study
.
Diabetologia
2012
;
55
:
681
688
[PubMed]
12.
Elks
CE
,
Ong
KK
,
Scott
RA
, et al.;
InterAct Consortium
.
Age at menarche and type 2 diabetes risk: the EPIC-InterAct study
.
Diabetes Care
2013
;
36
:
3526
3534
[PubMed]
13.
Mueller
NT
,
Duncan
BB
,
Barreto
SM
, et al
.
Earlier age at menarche is associated with higher diabetes risk and cardiometabolic disease risk factors in Brazilian adults: Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
.
Cardiovasc Diabetol
2014
;
13
:
22
[PubMed]
14.
Apter
D
,
Reinilä
M
,
Vihko
R
.
Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood
.
Int J Cancer
1989
;
44
:
783
787
[PubMed]
15.
Bartha
JL
,
Comino-Delgado
R
,
Romero-Carmona
R
,
Gomez-Jaen
MC
.
Sex hormone-binding globulin in gestational diabetes
.
Acta Obstet Gynecol Scand
2000
;
79
:
839
845
[PubMed]

Supplementary data